Design, synthesis, and preliminary pharmacological evaluation of new quinoline derivatives as nicotinic ligands. 2007

Luca Guandalini, and Monica Norcini, and Katia Varani, and Marco Pistolozzi, and Cecilia Gotti, and Carla Bazzicalupi, and Elisabetta Martini, and Silvia Dei, and Dina Manetti, and Serena Scapecchi, and Elisabetta Teodori, and Carlo Bertucci, and Carla Ghelardini, and Maria Novella Romanelli
Laboratory of Design, Synthesis and Study of Biologically Active Heterocycles (HeteroBioLab), Department of Pharmaceutical Sciences, University of Florence, via Ugo Schiff 6, I-50019 Sesto Fiorentino, Italy.

A series of nicotinic ligands, carrying a quinoline nucleus, and characterized by a pharmacophoric distance between the quinoline nitrogen (H-bond acceptor) and the cationic nitrogen atoms higher than that proposed in the classical pharmacophoric models, have been synthesized and tested for their affinity for the central nicotinic receptor. The enantiomers of the nicotine analogue 1-methyl-2-pyrrolidinyl-6-quinoline and of its methiodide display enantioselectivity in binding studies, but not when tested in vivo; on alpha7* nicotinic receptor enantioselectivity is inverted with respect to the alpha4beta2* subtype. N,N,N-Trimethyl-4-(quinolin-6-yl)but-3-yn-1-ammonium iodide (3c) and trans-N,N,N-trimethyl-4-(quinolin-6-yl)but-3-en-1-ammonium iodide (4c), showing pharmacophoric distances in the range 8.5-10.4 A, interact with the alpha4beta2* nicotinic receptor with Ki in the microM range; compound 3c shows preference for the alpha7* subtype.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D010147 Pain Measurement Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies. Analgesia Tests,Analogue Pain Scale,Formalin Test,McGill Pain Questionnaire,Nociception Tests,Pain Assessment,Pain Intensity,Pain Severity,Tourniquet Pain Test,Visual Analogue Pain Scale,Analog Pain Scale,Assessment, Pain,McGill Pain Scale,Visual Analog Pain Scale,Analgesia Test,Analog Pain Scales,Analogue Pain Scales,Formalin Tests,Intensity, Pain,Measurement, Pain,Nociception Test,Pain Assessments,Pain Intensities,Pain Measurements,Pain Questionnaire, McGill,Pain Scale, Analog,Pain Scale, Analogue,Pain Scale, McGill,Pain Severities,Pain Test, Tourniquet,Questionnaire, McGill Pain,Scale, Analog Pain,Scale, Analogue Pain,Scale, McGill Pain,Severity, Pain,Test, Analgesia,Test, Formalin,Test, Nociception,Test, Tourniquet Pain,Tests, Nociception,Tourniquet Pain Tests
D011804 Quinolines
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer

Related Publications

Luca Guandalini, and Monica Norcini, and Katia Varani, and Marco Pistolozzi, and Cecilia Gotti, and Carla Bazzicalupi, and Elisabetta Martini, and Silvia Dei, and Dina Manetti, and Serena Scapecchi, and Elisabetta Teodori, and Carlo Bertucci, and Carla Ghelardini, and Maria Novella Romanelli
February 2017, European journal of medicinal chemistry,
Luca Guandalini, and Monica Norcini, and Katia Varani, and Marco Pistolozzi, and Cecilia Gotti, and Carla Bazzicalupi, and Elisabetta Martini, and Silvia Dei, and Dina Manetti, and Serena Scapecchi, and Elisabetta Teodori, and Carlo Bertucci, and Carla Ghelardini, and Maria Novella Romanelli
June 2017, MedChemComm,
Luca Guandalini, and Monica Norcini, and Katia Varani, and Marco Pistolozzi, and Cecilia Gotti, and Carla Bazzicalupi, and Elisabetta Martini, and Silvia Dei, and Dina Manetti, and Serena Scapecchi, and Elisabetta Teodori, and Carlo Bertucci, and Carla Ghelardini, and Maria Novella Romanelli
June 2016, European journal of medicinal chemistry,
Luca Guandalini, and Monica Norcini, and Katia Varani, and Marco Pistolozzi, and Cecilia Gotti, and Carla Bazzicalupi, and Elisabetta Martini, and Silvia Dei, and Dina Manetti, and Serena Scapecchi, and Elisabetta Teodori, and Carlo Bertucci, and Carla Ghelardini, and Maria Novella Romanelli
September 2019, European journal of medicinal chemistry,
Luca Guandalini, and Monica Norcini, and Katia Varani, and Marco Pistolozzi, and Cecilia Gotti, and Carla Bazzicalupi, and Elisabetta Martini, and Silvia Dei, and Dina Manetti, and Serena Scapecchi, and Elisabetta Teodori, and Carlo Bertucci, and Carla Ghelardini, and Maria Novella Romanelli
October 2018, Bioorganic & medicinal chemistry letters,
Luca Guandalini, and Monica Norcini, and Katia Varani, and Marco Pistolozzi, and Cecilia Gotti, and Carla Bazzicalupi, and Elisabetta Martini, and Silvia Dei, and Dina Manetti, and Serena Scapecchi, and Elisabetta Teodori, and Carlo Bertucci, and Carla Ghelardini, and Maria Novella Romanelli
March 2016, European journal of medicinal chemistry,
Luca Guandalini, and Monica Norcini, and Katia Varani, and Marco Pistolozzi, and Cecilia Gotti, and Carla Bazzicalupi, and Elisabetta Martini, and Silvia Dei, and Dina Manetti, and Serena Scapecchi, and Elisabetta Teodori, and Carlo Bertucci, and Carla Ghelardini, and Maria Novella Romanelli
October 2019, Bioorganic & medicinal chemistry,
Luca Guandalini, and Monica Norcini, and Katia Varani, and Marco Pistolozzi, and Cecilia Gotti, and Carla Bazzicalupi, and Elisabetta Martini, and Silvia Dei, and Dina Manetti, and Serena Scapecchi, and Elisabetta Teodori, and Carlo Bertucci, and Carla Ghelardini, and Maria Novella Romanelli
May 2010, Bioorganic & medicinal chemistry,
Luca Guandalini, and Monica Norcini, and Katia Varani, and Marco Pistolozzi, and Cecilia Gotti, and Carla Bazzicalupi, and Elisabetta Martini, and Silvia Dei, and Dina Manetti, and Serena Scapecchi, and Elisabetta Teodori, and Carlo Bertucci, and Carla Ghelardini, and Maria Novella Romanelli
January 2011, Arzneimittel-Forschung,
Luca Guandalini, and Monica Norcini, and Katia Varani, and Marco Pistolozzi, and Cecilia Gotti, and Carla Bazzicalupi, and Elisabetta Martini, and Silvia Dei, and Dina Manetti, and Serena Scapecchi, and Elisabetta Teodori, and Carlo Bertucci, and Carla Ghelardini, and Maria Novella Romanelli
April 2022, Molecular diversity,
Copied contents to your clipboard!